WinSanTor is a clinical stage healthcare company developing disease modifying treatments for peripheral neuropathy. WinSanTor is the assembly of the leading researchers and clinicians gathered and funded by the leading stakeholders to solve this significant unmet need affecting 100s of millions of people. WinSanTor is advancing novel science showing prevention/reversal of the tortuous debilitating symptoms through regrowth of peripheral nerves. WinSanTor has had the luxury to not focus on investor returns and thus is focused on patient impact.
WinSanTor is presenting as part of the NIH Innovation Zone.